Patents by Inventor Kenia Jayvanti

Kenia Jayvanti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues
    Patent number: 6809177
    Abstract: The invention relates to a process for the conversion of echinocandin class of peptides to their C4-homotyrosine monodeoxy analogues, particularly mulundocandin to deoxymulundocandin, which consists of a single step selective reduction of C4-htyr (homotyrosine) hydroxyl group of echinocandins to their monodeoxy analogues under neutral conditions without prior protection/deprotection of the equally facile C5-Orn (ornithine) hydroxyl group and purification of the monodeoxy compound from the crude reaction mixture.
    Type: Grant
    Filed: March 29, 2001
    Date of Patent: October 26, 2004
    Assignee: Aventis Pharma Deutschland GmbH.
    Inventors: Triptikumar Mukhopadhyay, Kenia Jayvanti, Erra Koteswara Satya Vijaya Kumar
  • Kodaistatins A, B, C and D, a process for their production and their use
    Patent number: 6166070
    Abstract: Kodaistatins A and B, compounds of the molecular formula C.sub.35 H.sub.34 O.sub.11, and Kodaistatins C and D, compounds of the molecular formula C.sub.35 H.sub.34 O.sub.12, have antidiabetic activity.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: December 26, 2000
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Nirogi Venkata Satya Ramakrishna, Keshavapura Hosamane Sreedhara Swamy, Erra Koreswara Satya Vijayakumar, Suresh Rudra Nadkarni, Kenia Jayvanti, Andreas Herling, Herbert Kogler, Laszlo Vertesy, Rajan Mukund Panshikar, Kota Sridevi, Mythili Raman, Roda Maneck Dalal